acetazolamide has been researched along with Age-Related Macular Degeneration in 6 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with acetazolamide, at a dosage of 0." | 5.28 | [Serous retinal detachment. Value of acetazolamide]. ( Gonzalez, C, 1992) |
| "05 mL of bevacizumab or ranibizumab), that were divided into five groups, group 1: no intraocular pressure (IOP)-lowering medication (n=50); group 2: apraclonidine 1 % one drop 2 hours prior to IVI (n=50); group 3: acetazolamide 250 mg 2 hours prior (n=50); group 4: fixed combination brimonidine+timolol (n=30); group 5: fixed combination dorzolamide+timolol (n=30)." | 5.16 | [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections]. ( Dot, C; El Chehab, H; Giraud, JM; Le Corre, A; Ract-Madoux, G; Swalduz, B, 2012) |
| "The primary lesion in dominant cystoid macular dystrophy remains obscure." | 1.29 | Acetazolamide in dominant cystoid macular dystrophy. A pilot study. ( Aandekerk, AL; Cruysberg, JR; Kremer, H; Pinckers, A, 1993) |
| "Treatment with acetazolamide, at a dosage of 0." | 1.28 | [Serous retinal detachment. Value of acetazolamide]. ( Gonzalez, C, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abouzeid, H | 1 |
| Wolfensberger, TJ | 1 |
| Schorderet, DF | 1 |
| Munier, FL | 1 |
| El Chehab, H | 1 |
| Le Corre, A | 1 |
| Giraud, JM | 1 |
| Ract-Madoux, G | 1 |
| Swalduz, B | 1 |
| Dot, C | 1 |
| Hori, K | 1 |
| Ishida, S | 1 |
| Inoue, M | 1 |
| Shinoda, K | 1 |
| Kawashima, S | 1 |
| Kitamura, S | 1 |
| Oguchi, Y | 1 |
| López-Menchero, R | 1 |
| Albero, MD | 1 |
| Barrachina, MD | 1 |
| Alvarez, L | 1 |
| Pinckers, A | 1 |
| Cruysberg, JR | 1 |
| Kremer, H | 1 |
| Aandekerk, AL | 1 |
| Gonzalez, C | 1 |
1 review available for acetazolamide and Age-Related Macular Degeneration
| Article | Year |
|---|---|
[Anuric acute renal failure due to acetazolamide].
Topics: Acetazolamide; Acute Kidney Injury; Anuria; Back Pain; Diagnosis, Differential; Fluid Therapy; Furos | 2006 |
1 trial available for acetazolamide and Age-Related Macular Degeneration
| Article | Year |
|---|---|
[Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
Topics: Acetazolamide; Aged; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Bevacizumab; Brimon | 2012 |
4 other studies available for acetazolamide and Age-Related Macular Degeneration
| Article | Year |
|---|---|
Unilateral macular oedema in Zermatt and Stargardt macular dystrophies.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Diagnostic Techniques, Ophthalmological; Female | 2009 |
Treatment of cystoid macular edema with oral acetazolamide in a patient with best vitelliform macular dystrophy.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Female; Fluorescein Angio | 2004 |
Acetazolamide in dominant cystoid macular dystrophy. A pilot study.
Topics: Acetazolamide; Administration, Oral; Adult; Female; Fundus Oculi; Humans; Macular Degeneration; Macu | 1993 |
[Serous retinal detachment. Value of acetazolamide].
Topics: Acetazolamide; Aging; Drug Evaluation; Female; Fluorescein Angiography; Humans; Macular Degeneration | 1992 |